Last reviewed · How we verify

NCT06737120

Effect of Modified Free Gingival Graft and Conventional Free Gingival Graft on Gingival Recession

Not yet recruiting NA Last updated 17 December 2024
What this trial tests

NA trial testing Mod-fgg in Gingival Recession, Localized in 60 participants. Not yet recruiting.

Timeline
30 December 2024
Primary endpoint
30 March 2025
30 July 2025

Quick facts

Lead sponsorAYSE HUMEYRA ORUC
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date30 December 2024
Primary completion30 March 2025
Estimated completion30 July 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

AYSE HUMEYRA ORUC

Who can join

Adults 18 to 65, any sex, with Gingival Recession, Localized or Keratinized Tissue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical study is to understand whether the modified free gingival graft technique is superior to the conventional free gingival graft: Will gingival recession completely close in modified free gingival grafting areas? Will there be a significant increase in the amount of keratinized gingiva in modified free gingival grafting participants compared to traditional free gingival grafting participants? Participants will visit our clinic in the 1st, 3rd and 6th months. Necessary clinical parameter measurements will be made by the clinician.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gingival Recession, Localized

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06737120.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing